Safety and Efficacy Study of DCVax-Direct in Solid Tumors

PHASE1/PHASE2UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2016

Conditions

Locally Advanced TumorMetastatic Solid Tissue TumorsLiver CancerColorectal CancerPancreatic CancerMelanoma

Interventions

BIOLOGICAL

DCVax-Direct

Autologous, activated dendritic cells for intratumoral injection

Trial Locations (2)

Orlando Health, Orlando

MD Anderson Cancer Center, Houston